Make An Appointment Make A Payment Event Registration
Make an appointment

Todd Sack, M.D.

Todd Sack, M.D.

Dr. Sack trained at Yale College, the University of California School of Medicine at San Francisco, Columbia - Presbyterian Medical Center, and had his fellowship at the University of California School of Medicine, San Francisco, California. He was a Assistant Professor of Medicine at the University of California School of Medicine in San Francisco as a research biochemist studying pancreatic and colon cancer. He has been with the Borland Groover Clinic since 1988. He is an active member of our clinical research team, serving as an a principle investigator on numerous active clinical trials being conducted at our clinic. In addition, Dr. Sack continues his interest in medical education as serving as the past director of continuing education for the Department of Medicine at St. Vincent’s Hospital and as an educator within the Family Practice Residency program.

Dr. Sack directs the Borland Groover Clinic teaching program for the Family Practice residents from St Vincent’s. He is past President of the Duval County Medical Society, is Chairman of the Florida Medical Association’s Environment and Health Section, was two-term member and Chairman of the Jacksonville Environmental Protection Board, served as a member of the Florida Energy Commission and chaired the Florida Legislature’s Climate Change Advisory Group. He is helping the Clinic develop our Green Teams.

Office locations

St. Vincent’s / Dillon Building Office
Memorial Medical Office

Practicing since

1988

Certifications

  • Board Certified, Gastroenterology, 1985
  • Board Certified, Internal Medicine, 1983

National Provider Identifier

1366434136

Licensure

Florida, California

Professional Clinical Positions

Professional Clinical Positions
1988 - Present Borland-Groover Clinic, P.A. Jacksonville, Florida

Administrative and Leadership Positions

Administrative and Leadership Positions
1987 – 1988 Assistant Professor of Medicine and Attending Physician University of California School of Medicine San Francisco, California
1985 – 1988 Instructor in Medicine University of California School of Medicine San Francisco, California
1985 – 1988 Associate Investigator Veterans Administration Medical Center San Francisco, California

Medical Education

Medical Education
1976 – 1980 M.D., University of California School of Medicine San Francisco, California

Postgraduate Education

Postgraduate Education
1983 - 1985 Fellow, Gastroenterology University of California School of Medicine San Francisco, California
1982 – 1983 Resident, Internal Medicine University of California School of Medicine San Francisco, California
1980 – 1982 Resident, Internal Medicine Columbia–Presbyterian Medical Center New York, New York

Undergraduate Education

Undergraduate Education
1972 – 1976 B.S. (cum laude), Yale College New Haven, Connecticut

Professional Associations

  • Duval County Medical Society:
    • Member, 1988 - Present
    • President, 2001
    • President Elect, 2000
    • Membership Committee: Chairman, 2003 - 2008, member 2002 - Present
    • Web Site Committee 2000 - 2004
    • Member, Board of Directors, 1993 - 2002, 2009
    • Treasurer, 1998 - 1999
    • Secretary, 1997
    • Health Disparities Task Force 2001
    • Tort Reform Ad Hoc Committee, Member 2002 - 2003
    • Judicial Committee, Chairman, 2004, member 2003 - 2004
    • Nominating Committee: Chairman 2002
    • Corporate Sponsorship Oversight Committee 2000 - 2001
    • Editorial Committee: Member, 1990 - 1993
    • John A. Beals Award for Medical Research, Committee Chairman, 1990 - 1996, Member 1989 - 1996
    • Public Relations Committee, Member, 1991–1997, Chairman 1996 - 1998
    • Guest Editor, Jacksonville Medicine, July 1991, July 2002
    • Young Physician Section, Steering Committee member, 1989 - 1990

  • Florida Medical Association, Member, 1988 - Present

    • Environment & Health Section, Chairman, 2002 - Present
    • Environmental Health Work Group, Chairman, 2001
    • Finance Committee - 2002
    • Reference Committee Finance & Administration, Member 2000
    • Delegate 1992 - Present

  • We Care,  Jacksonville, Inc.  (Healthcare for the uninsured)

    • President, 2012-2013
  • Community Environmental Health Advisory Board (FL Department of Health), Member 2006-2008

  • Florida Energy Commission, member 2006-2008

    • Climate Change Advisory Group, Chairman 2007
  • FLAMPAC Board of Directors, member 2003–2008, Amendment 3 Campaign “Eagle Award” recipient

  • Environment & Health Section, Florida Medical Association, Chairman, 2002 - present

    • Co-Author, The Green Doctor Office Program (mygreendoctor.org), 2010
  • FLAMPAC “1000 Club” member 2000 - Present
  • Yulee Historic Council (John Muir Ecological Park), Board Member 2000 - present

  • Jacksonville Environmental Protection Board, Board member 1998 - 2006

    • Chairman, 2003 - 2006
  • Meninak of Jacksonville,  Member, 1989 - present
  • American Medical Association, Member, 1988 - Present
  • American College of Physicians:  Member, 1987 - Present; Fellow, 1990 - Present
  • American Gastroenterology Association:  Member, 1987 - Present
  • American Society of Gastrointestinal Endoscopy, Member, 1990 - 2009
  • Florida Gastroenterological Society, Member,1990 - 1995, 2002 - 2007
  • Florida Society of Internal Medicine, Member, 1993 - 1999, Board of Directors, 1997 - 1998

Publications

Hwang WI, Sack TL, Kim YS. Effects of cyclic-adenosine 3’: 5’ - monophosphate upon glycoprotein and carcinoembryonic antigen synthesis and release by human colon cancer cells. Cancer Research 1986; 46:  337–3374

Sack TL, Gum J, Kim YS. Cyclic-AMP-stimulated synthesis and release of carcinoembryonic antigen by pancreatic cancer cells. International Journal of Pancreatology, 1988; 3:  171–184

Sack TL, Gum JR, Low M, Kim YS. Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol - specific phospholipase C. Journal of Clinical Investigation, 1988; 82:  586–593

Toribara N, Sack TL, Gum JR, Ho SB, Shively JE, Wilson JKV, Kim YS. Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines. Cancer Research, 1989; 49: 3321–3327

Gum GR, Hicks JW, Sack TL, Kim YS. Molecular cloning of complementary cDNA’s encoding alkaline phosphatase in human colon cancer cells. Cancer Research 1990; 50: 1085–1091

Sack TL. The medical acute abdomen: a diagnostic guide. Jacksonville Medicine 1993; 44: 65–67

Sack TL. The new hepatitis alphabet: A through E. Jacksonville Medicine 1993; 44: 167–169

Sack TL. Primary Biliary Cirrhosis, Jacksonville Medicine 2001

Bresalier RS, Borland CR, Sack TL, Kim YS. Cancer of the gastrointestinal tract. In Kern F Jr., Blum AL (Eds): The Gastroenterology Annual, 3. New York: Elsevier, 1986: 413–469

Sack TL, Kim YS. Pancreatic cancer - associated carbohydrate antigens. In Delmont J. (Ed): Cancer of the Exocrine Pancreas. Basel: Karger, 1986: 48–59

Sack TL, Sleisenger MS. Effects of systemic and extraintestinal disease upon the gut. In Sleisenger MS, Fordtran JH (Eds): Gastrointestinal Disease: Pathophysiology, Diagnosis, and Management, (4th Edition). Philadelphia: Saunders, 1988:  488–528

Sack TL, Silverman S. Jr., Oral disease and cutaneous manifestations of gastrointestinal disease. In Sleisenger MS, Fordtran JH (Eds): Gastrointestinal Disease: Pathophysiology, Diagnosis, and Management, (4th Edition), Philadelphia:  Saunders, 1988:  529–538

Abstracts

Sack TL, Hicks J, Kim YS.  Cyclic - AMP increases the release and content of carcinoembryonic antigen from human pancreatic cancer cells in vitro. Gastroenterology 1985; 88: 1566. Oral presentation at the AGA Annual Meeting, May 1985

Sack TL, Hwang WI, Kim YS. Cyclic - AMP increases the synthesis and release of glycoproteins and carcinoembryonic antigen by human colonic cancer cells. Clinical Research 1986;34: 36A

Sack TL, Gum JR, Kim YS. Carcinoembryonic antigen release by colon cancer cells: role of phosphatidylinositol-specific phospholipase C. Gastroenterology 1987;92: 1608. Oral presentation at the AGA Annual Meeting, May 1987

Sack TL. Porphyrin excretion and hepatic porphyrin content in hepatoma – associated porphyria. Hepatology 1987; 7: 1098

Sack TL, Gum JR, Kim YS. Carcinoembryonic antigen and placental - like alkaline phosphatase release by human colon cancer cells: presence of covalently - bound lipid and release by exogenous or endogenous phosphatidylinositol – specific phospholipase C. Gastroenterology 1988; 94:  A393. Oral presentation at the AGA Annual Meeting, May 1988

Toribara NW, Sack TL, Gum JR, Kim YS. Effects of sodium butyrate on expression of carcinoembryonic antigen (CEA) family genes by human neoplastic colon cells. Gastroenterology, 1988; 94: A646

  • Intron A + Ribavirin for Treatment of Patients with Chronic Hepatitis C Not Previously Treated with Interferon, Schering Corporation
  • Intron A + Ribavirin for Treatment of Patients with Interferon-Refractory or Interferon-Relapsed Chronic Hepatitis C, Schering Corporation
  • A 12-Week, Randomized, Double Blind, Placebo-Controlled Study of Alosetron (GR68755) in Female Subjects with Irritable Bowel Syndrome, Glaxo Wellcome, Inc.
  • A Double-Blind, Placebo-Controlled Pilot Trial to Determine the Efficacy and Safety of Cisapride in Improving Respiratory Symptoms and Pulmonary Function in Asthmatics with Gastroesophageal Reflux (GER), Janssen Research Foundation
  • A 12-Week, Dose-Ranging, Double-Blind, Placebo-Controlled Study of Alosetron (GR68755) in Subjects with Irritable Bowel Syndrome
  • A Multicenter Study on the Efficacy and Safety of HOE 760 vs. Placebo in the Long Term Maintenance Treatment of Duodenal Ulcer Disease
  • A Multicenter, Randomized, Double-Blind, Evaluation of Helicobacter pylori Eradication Following Oral GR122311X in Combination with Clarithromycin Compared to Omeprazole in Combination with Clarithromycin, Glaxo Wellcome, Inc.
  • A Comparison of Ranitidine 300 mg and Cimetadine 800 mg Administered at Bedtime for the Treatment of Large Duodenal Ulcers
  • A Comparison of Ranitidine 300 mg and Cimetadine 800 mg Administered at Bedtime for the Treatment of Small Duodenal Ulcers
  • A Comparison of Ranitidine 150 mg and Ranitidine 300 mg Administered at Bedtime for the Maintenance of Healed Duodenal Ulcers
  • A Comparison of Ranitidine 150 mg and Ranitidine 300 mg QID and Placebo in the Treatment of Erosive Esophagitis
  • A Comparison of Ranitidine 150 mg BID and Placebo in the Maintenance of Healed Erosive Esophagitis
  • A Comparison of Ranitidine 300 mg HS, Ranitidine 300 mg BID, Ranitidine 300 mg TID, and Ranitidine 300 mg QID in the Treatment of Duodenal Ulcer Disease
  • A Double-Blind, Multicenter Study to Investigate the Efficacy of Omeprazole 20 or 40 mg Once Daily in the Healing of and Relief of Symptoms due to Benign Gastric Ulcers
  • A Comparison of Ranitidine/Bismuth Citrate Compared with Ranitidine and Placebo for Prophylaxis of NSAID Associated Ulcers in Patients with OA or RA without a History of Ulcer
  • Dose Ranging Study of the Safety and Efficacy of Oral Doses of Zileuton for Eight Weeks in Patients with Ulcerative Colitis
  • Long Term Safety and Efficacy of Zileuton in Patients with Ulcerative Colitis in Remission
  • A Phase III Study Comparing Colazide with Asacol in Patients with Ulcerative Colitis
  • A Double Blind, Multicenter Study to Evaluate the Efficacy of Cisapride 20 mg BID